Participants included in the trial have been diagnosed with either aortic dissection or aneurysm involving the aortic arch.

Artivion, Inc. , a leading cardiac and vascular surgery company focused on aortic disease, today announced the treatment of the first patient in the ARTIZEN pivotal trial, evaluating the safety and ...

Endovascular Stent Grafts Market to Reach $1.76 billion by 2032, Driven by Aging Populations and Advances in Device Durability Request for customizatio  The global Endovascular Stent Grafts ...

Low-risk patients with severe, symptomatic aortic stenosis show similar clinical outcomes and valve durability ...

People living with aortic stenosis (AS) could gain earlier access to innovative care and treatment thanks to a new effort ...

The #1 Rule Experts Say to Follow When You Forget Wet Clothes in the Washer King Charles strips Andrew of royal titles and ...

Investigators have discovered a new pathway that may lead to a treatment for high blood pressure and aortic aneurysms. By creating a new laboratory model for studying these conditions, the team ...

Intermountain Health surgeons have achieved a medical milestone for Utah patients by successfully performing the state’s first minimally invasive ascending ...

In performing open arch replacement, surgeons at our center and others currently prefer to reattach the individual brachiocephalic branches separately, rather than reattaching a single island of ...

Artivion Inc. (($AORT)) announced an update on their ongoing clinical study. Artivion Inc. has announced a new clinical study titled ‘A ...

Management of recoarctation in children is often dictated by age and anatomical complexity. Therapeutic interventions include balloon angioplasty, transcatheter stent implantation, and less commonly, ...

Following the bye, quarterback Arch Manning and the Texas Longhorns open up Southeastern Conference play on the road in Gainesville, taking on the Florida Gators. Ahead of this test for Manning, ...